Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedUpdated page to v3.2.0, added government-status notice about potential delays, and removed a resource on Mature T-cell and NK-cell non-Hodgkin lymphoma.SummaryDifference3%
- Check25 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%
- Check39 days agoChange DetectedUpdates the page from Revision: v3.0.1 to Revision: v3.0.2, signaling a new release. The 'Back to Top' link/element has been removed, a minor navigation-quality change.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location details, as well as specific medical conditions related to non-Hodgkin lymphoma. Several previous location references and related medical topics have been removed.SummaryDifference12%
- Check61 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.